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Objective: To estimate the 12-month prevalence of mental health services utilization (overall and by
type of service sector), the adequacy of treatment provided, and sociodemographic correlates in the
Argentinean Study of Mental Health Epidemiology (ASMHE).
Methods: The ASMHE is a multistage probability household sample representative of adults in urban
areas of Argentina. The World Health Organization World Mental Health Composite International
Diagnostic Interview (WMH-CIDI) was used to evaluate psychiatric diagnosis and service utilization.
Results: Among those with a disorder, 27.6% received any treatment in the prior 12 months. Of these,
78.3% received minimally adequate treatment using a broad definition and only 43.6% using a stringent
definition. For individuals with a disorder, more services were provided by mental health professionals
(17.7%) than by general medical professionals (11.5%) or non-healthcare sectors (2.6%). Younger
individuals with low education and income were less likely to receive treatment; those never married
and those with an anxiety or mood disorder were more likely to receive treatment. Among those in
treatment, treatment was least adequate among younger individuals with low education and low income.
Conclusions: Policies to increase access to services for mental health disorders in Argentina are
needed, as is training for primary care practitioners in the early detection and treatment of psychiatric
disorders.
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Introduction
Mental and substance use disorders are important and
increasing causes of years of life lived with disability
(YLDs), disability-adjusted life years (DALYs), and years
of life lost (YLLs).1-3 For example, depression and anxiety
disorders are among the ten leading causes of YLDs
globally.1 In Argentina, DALYs attributed to mental and
substance use disorders have increased 9.7% from 2005
to 2013, and self-harm is the tenth leading cause of YLL.2,3
To meet the challenges posed by mental and substance
use disorders and to adjust healthcare organization and
policies accordingly, an understanding of treatment use
and adequacy is imperative.
While the availability of effective treatments for psy-
chiatric disorders is increasing worldwide, it is difficult to
extend these advances to the majority of people in all
countries, and a significant portion of the population with
mental health disorders does not receive treatment.
According to the World Mental Health (WMH) surveys
conducted in 17 countries by the World Health Organi-
zation (WHO),4 12-month service utilization for mental
disorders was generally lower in developing than devel-
oped countries, ranging from 1.6% in Nigeria to 17.9%
in the United States. Most treatment was provided by a
general medical provider in all countries except Colombia,
Mexico, and Israel, where more individuals received treat-
ment from mental health specialists. Among those initia-
ting care, most had at least one follow-up session, but not
even half received minimally adequate care. The socio-
demographic factors associated with seeking treatment
for mental health disorders in other Latin American
countries – namely, Mexico and Colombia – included
female sex; having a severe disorder; being separated,
widowed, or divorced (only for Colombia); and high income
(only for Colombia).4
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A survey conducted in Mexico5 with methods and mea-
surement instruments similar to those of the current study
found that less than one in five respondents with any
psychiatric disorder during the 12 months preceding
the interview had used any mental health service during
that time. Approximately one in every two respondents
who used services received minimally adequate care,
mostly in the mental health specialty sector. Rates of
service utilization were higher for severe disorders and
mood disorders in particular.
The Argentinean Study of Mental Health Epidemiology
is the first general-population survey to provide a pano-
rama of treatment utilization for mental health and sub-
stance use disorders in Argentina. The objectives of this
report are to retrospectively estimate the 12-month pre-
valence of service utilization (overall and by type of service
sector), the adequacy of treatment for specific mental
health disorders, and sociodemographic correlates of
service utilization.
Methods
Sample
The Argentinean Study of Mental Health Epidemiology
was conducted in 2015. Based on the methodological
requirements established by the WMH Survey Initiative,6
it employed a complex multistage probability sampling
design7 to represent the non-institutionalized adult popu-
lation (aged 18 and over), with stable residence, living in
the eight largest urban agglomerations of Argentina: the
metropolitan areas of Buenos Aires, Co´rdoba, Corrientes-
Resistencia, Mendoza, Neuque´n, Rosario, Salta, and
Tucuma´n. The response rate for the first phase of the
survey was 77% (n=3,997). All respondents who were
positive on initial screening, as well as a random sub-
sample of those who were not, completed the second
phase of the survey, which collected data on service
utilization and treatment adequacy. The following ana-
lyses are based on this second-phase subsample of
2,116 participants.
Instrument
Psychiatric diagnosis and service utilization was meas-
ured with the WHO WMH Composite International Diag-
nostic Interview (CIDI), pilot-tested by the Argentinean
team to adapt it to the local language and culture.8 This
structured diagnostic interview was administered face-to-
face by trained interviewers, using the Computer-Assisted
Personal Interviewing (CAPI) survey technique. The CIDI
has demonstrated adequate concordance with clinical
diagnoses9 based on the Structured Clinical Interview for
DSM-IV (SCID).10
Diagnostic evaluation
The CIDI provides diagnoses based on DSM-IV diagnos-
tic criteria.11 For this article, we report on mental disorders
present in the 12 months prior to the interview. These
disorders include: 1) Mood disorders (major depressive
episode, bipolar disorder I or II, and dysthymia); 2) Anxiety
disorders (panic disorder, agoraphobia without panic dis-
order, social phobia, specific phobia, separation anxiety
disorder, generalized anxiety disorder [GAD], and post-
traumatic stress disorder); 3) Substance disorders (alco-
hol and drug abuse and dependence); and 4) Disruptive
behavior disorders (oppositional-defiant disorder, conduct
disorder, and attention-deficit/hyperactivity disorder).
Treatment contact
Respondents were asked if they had, in the past 12 months,
consulted any of several different types of professionals
for problems with emotions, nerves, mental health, or use
of alcohol or drugs. The type of service provider was clas-
sified into healthcare sector and non-healthcare sector.
The healthcare sector was further classified into mental
health professionals and general medical professionals.
Mental health professionals were further grouped into
psychiatrists and other mental health professionals (con-
sisting of psychologists, counselors, psychotherapists,
mental health nurses, and social workers in a mental
health specialty setting). General medical professionals
consisted of family physicians, general practitioners, and
other medical doctors, such as cardiologists, or gynecol-
ogists (for women) and urologists (for men), as well as
nurses, occupational therapists, or other healthcare pro-
fessionals. The non-healthcare sector was classified into
human services (including social workers or counselors in
any setting other than a specialty mental health setting, as
well as religious or spiritual advisors, such as a minister,
priest, or rabbi), and complementary-alternative medicine
(CAM) (including internet use, self-help groups, any other
healer – such as an herbalist, a chiropractor, or a spirit
medium – and other alternative therapy).
Minimally adequate treatment
Based on the definition established in prior WMH Surveys,4
we defined minimally adequate treatment during the pre-
vious 12 months as either: 1) four or more outpatient
psychotherapy visits to any provider; or 2) two or more
outpatient pharmacotherapy visits to any healthcare
provider and treatment with any medication for any length
of time; or 3) reporting still being ‘‘in treatment’’ at the time
of the interview. Although this definition is broader than
that used in previous WMH Surveys, it allowed us to
obtain conservative estimates of minimally adequate
treatment across sectors. In sensitivity analyses, a more
stringent definition of minimally adequate treatment was
also used, in which we required: 1) eight or more visits to
any service sector for psychotherapy; or 2) four or more
visits to any service sector and 30 or more days taking
any medication for pharmacotherapy.
Correlates
Sociodemographic correlates of any 12-month treatment
contact and minimally adequate treatment examined here
included sex, age at interview (18-34 years, 35-49 years,
50-64 years, and 65 years or older), educational attainment
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(low, low-average, high-average, and high), income (low,
low-average, high-average, and high), and marital status
(never married, separated/widowed/divorced, married/cohab-
iting). These correlates were chosen to allow compar-
isons with the findings of other WMH Surveys, particularly
those conducted in other Latin American countries.4-5
Procedures
Fieldwork was coordinated and directed by the Universi-
dad Nacional de Tres de Febrero (UNTREF). Interviewers
with experience in the health sector were trained for this
survey and distributed across local teams. All interviews
were administered at the respondents’ households. The
selected participants were told that participation was
voluntary and anonymous and that the information obtained
would only be used for prevention and public health pur-
poses, and were asked to give their informed consent.
Ethics
Research design and procedures for the present study
were approved by the ethics committee of the Facultad de
Medicina, Universidad de Buenos Aires.
Analyses
Post-stratification to the urban Argentinean population
in the target age and sex range (according to the 2010
census) was performed. Data for respondents in the
second-phase subsample were weighted to adjust for the
differential probability of selection. Estimates of standard
errors for proportions were obtained by the Taylor series
linearization method with SUDAAN software.12 Logistic
regression analysis was performed to study sociodemo-
graphic correlates.13 Two parallel analyses were perfor-
med: one for receiving any treatment among those with
disorders and a second one for receiving minimally ade-
quate treatment among those with disorders who received
any treatment. Estimates of standard errors of odds ratios
and corresponding standard errors from logistic regres-
sion coefficients were also obtained with SUDAAN, and
95% confidence intervals were adjusted for design effects.
Statistical significance was evaluated with two-sided
design-based tests, at the 0.05 level.
Results
As shown in Table 1, 11.6% of respondents reported
having used any service for the treatment of mental health
problems in the 12 months prior to the interview. As
expected, the proportion of any service utilization was
lower among respondents without any 12-month mental
disorder (8.8%) and higher among respondents with any
12-month disorder (27.6%). Respondents with mood and
anxiety disorders had the highest rates of service utili-
zation (35.5% and 30.1%, respectively). The individual
disorders with the highest service utilization rates were
panic disorder (53.7%), GAD (48%), dysthymia (44.2%),
and posttraumatic stress disorder (42.6%); alcohol abuse
with dependence accounted for the lowest service
utilization (14.5%). For some specific disorders with
unweighted no 30, the prevalence of service utilization
could not be calculated.
Among those with any disorder, more services were
provided by mental health professionals (17.8%) than by
general medical professionals (11.5%) or non-healthcare
sectors (2.6%), irrespective of type of disorder. More
specifically, other mental health professionals (i.e., non-
psychiatrists) provided the greatest proportion of services
for all disorders. The second and third sources of treat-
ment differed by type of disorder. Respondents with any
mood disorders made more use of psychiatrists than
general medical professionals, whereas respondents with
any anxiety disorders tended to use more general medical
professionals than psychiatrists. Among respondents with
any substance disorders, psychiatrists and general medi-
cal professionals had a similar proportion of use.
The median number of 12-month visits (Table 2) among
those receiving any treatment was 4.45. Due to cells with
unweighted no 30 or where the standard error could not
be calculated, the median number of service visits in the
past year is shown on Table 2 for classes of disorders
rather than individual disorders across type of treatment
provider. For the same reason, the median number of
visits for those with any substance use disorder could not
be calculated. The mean numbers of visits (data not
shown, but available upon request) was consistently
much higher than the median, due to a small number of
respondents who attended a large number of visits. For
example, among the total sample of respondents, the
mean number of visits for any treatment in the previous
year was 16.62, with very small differences in the mean
number of visits among respondents with or without psy-
chiatric disorders (16.07 and 16.91, respectively). Other
mental health professionals had the highest mean number
of visits (19.93), followed by psychiatrists (13.64 visits)
and general medical professionals (6.60 visits). Patients
with anxiety disorders had a higher mean number of visits
for any treatment than patients with mood disorders
(17.43 vs. 14.09 visits). The greater magnitude of means
than medians implies that comparatively few patients
receive a disproportionately high share of all visits.
Table 3 presents the adequacy of treatment over the
12-month period of analysis. Overall, 78.4% of those
receiving any services obtained treatment that could be
considered at least minimally adequate. There were
generally only minor differences across anxiety and mood
disorders. Again, due to limitations with cell sizes, only
classes of disorders are shown rather than individual
disorders, and the proportion of those getting minimally
adequate treatment for any substance use disorder could
not be estimated. Among those with any disorder, treat-
ment adequacy was greater when provided by mental
health professionals (81.5%) vs. general medical profes-
sionals (69.7%). There were insufficient cases of service
utilization in the non-healthcare sectors among those with
disorders to calculate adequacy. Of those with no disorder,
treatment adequacy was greater in the non-healthcare
sector (95.6%) than in the healthcare sector (80.8%).
In sensitivity analyses with our more stringent definition
of adequacy, the proportion of respondents obtaining
Braz J Psychiatry. 2018;00(00)
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minimally adequate treatment was 48.5%; that represents
roughly 30% less than when using the broad definition of
adequacy. Those with disorders receiving any minimally
adequate services decreased to 43.7% with our more
stringent definition. This proportion was 42.3% among
respondents with anxiety disorders and 44.4% among
those with mood disorders (data not shown, but available
upon request).
Table 4 presents the results of two multiple logistic
regression models, one for the sociodemographic and
disorder type correlates of any 12-month service utiliza-
tion and another for the sociodemographic and disorder
type correlates of minimally adequate treatment among
respondents with any service utilization. Being younger
(age o 35 years) and having lower educational level and
income were associated with lower odds of receiving any
treatment. Having never been married and having an
anxiety, mood, or substance use disorder was associated
with 1.7-, 3.2-, 3.6-, and 1.9-fold odds of service utilization,
respectively. Being younger, having a lower educational
level, and having a lower income were also associated
with lower odds of receiving minimally adequate treat-
ment among those receiving treatment; however, type
of disorder was not related to the likelihood of receiving
adequate treatment.
Discussion
Most individuals in the survey who had a mental disorder
in the 12 months preceding the interview did not receive
any treatment during this period. This finding indicates
a high level of unmet need for treatment in the urban
population of Argentina. Further research and policies are
needed to reduce treatment barriers and increase treat-
ment access. At 27.6%, the proportion of those with a
disorder who had received treatment in the 12 previous
months was somewhat higher than the proportions found
in the other Latin American countries included in the WMH
Surveys.4 Furthermore, the higher mean than median
number of visits implies that comparatively few patients
received a disproportionately high share of all visits.
Of the cases that received treatment, three-quarters
received minimally adequate treatment based on a broad
definition, but less than half received minimally adequate
treatment according to our more stringent definition. The
proportion receiving adequate treatment was higher among
patients seen by mental health professionals than among
those seen by general medical professionals. This points
to the need for further training of primary healthcare pro-
viders in basic mental health treatment guidelines. That
8.8% of respondents that did not meet full diagnostic
criteria for any disorder but received treatment nonetheless
may reflect individuals with subthreshold symptoms, receiv-
ing follow-up for relapse prevention, or in psychoanalysis
for self-actualization.14 In fact, for individuals not meeting
diagnostic thresholds, treatment adequacy was greater
when provided by non-healthcare professionals, perhaps
suggesting health professionals’ greater dismissal of their
concerns or efforts at ‘‘gatekeeping’’ for rational use of
services.15
Individuals with 12-month disorders who were aged o
35 years, with low education, and low income were less
likely than other cases to receive any treatment. Whether
this is due to economic factors or other barriers (such as
attitudes, beliefs and knowledge about psychiatric dis-
orders and their treatment, or structural barriers to access)
Table 2 Median number of service visits in the preceding year (Argentinean Study of Mental Health Epidemiology [ASMHE], 2015)
Disorder (group) Psychiatrist Other mental healthcare Any mental healthcare General medical Any healthcare Any treatment
Any anxiety 3.6 (2.0) (n=45) 11.54 (4.28) (n=63) 11.4 (4.98) (n=84) 1.64 (0.32) (n=62) 2.16 (1.00) (n=125) 1.96 (0.95) (n=130)
Any mood 3.89 (1.49) (n=43) 9.94 (2.93) (n=54) 9.95 (3.68) (n=78) (n=26) 5.42 (2.21) (n=94) 3.96 (2.01) (n=101)
Any substance (n=11) (n=7) (n=15) (n=6) (n=20) (n=21)
Any 3.92 (1.86) (n=63) 11.45 (3.01) (n=87) 11.39 (3.48) (n=121) 1.65 (0.15) (n=74) 3.95 (1.47) (n=170) 3.03 (1.02) (n=180)
None 5.24 (1.20) (n=65) 11.29 (2.85) (n=112) 10.43 (3.22) (n=156) 1.53 (0.25) (n=89) 5.8 (1.76) (n=229) 5.21 (1.74) (n=249)
All 4.96 (0.85) (n=128) 11.33 (2.27) (n=199) 11.25 (1.85) (n=277) 1.59 (0.13) (n=163) 5.39 (1.47) (n=399) 4.45 (0.96) (n=429)
Data presented as median (standard error).
Medians not shown for cells with unweighted n o 30 or where standard error could not be calculated.
Human services, CAM, and any non-healthcare service not included because n o 30.
Table 3 Proportion getting minimally adequate treatment among individuals receiving treatment (Argentinean Study of Mental
Health Epidemiology [ASMHE], 2015)
Disorder (unweighted n) Psychiatrist
Other mental
healthcare
Any mental
healthcare
General
medical
Any
healthcare
Human
services CAM
Any non-
healthcare
Any
treatment
Any anxiety (n=378) 80.63 (7.88) 78.24 (6.04) 76.42 (5.47) 74.9 (7.14) 72.49 (5.10) - - - 71.38 (5.15)
Any mood (n=261) 87.71 (6.42) 85.16 (5.14) 83.19 (5.54) - 74.34 (5.50) - - - 72.92 (5.16)
Any substance (n=73) - - - - - - - - -
Any (n=563) 82.87 (6.10) 83.23 (4.54) 81.52 (4.25) 69.73 (8.61) 74.08 (4.61) - - - 72.89 (4.61)
None (n=1,553) 85.4 (7.34) 87.49 (4.35) 85.75 (4.13) 71.59 (5.40) 80.83 (3.47) - - 95.58 (2.95) 81.27 (3.34)
All (n=2,116) 84.38 (4.79) 86.1 (3.35) 84.38 (3.24) 70.76 (5.55) 78.48 (2.88) 89.12 (6.50) - 90.38 (4.28) 78.37 (2.74)
Data presented as % (standard error).
CAM = complementary-alternative medicine.
Percentages not calculated for disorders with unweighted n o 30.
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is an important area for future inquiry.16 On the other
hand, those who had never been married and those who
had an anxiety or mood disorder were more likely than
other 12-month cases to receive treatment. Greater utili-
zation of services by never-married respondents has also
been found in five of the 17 other WMH Survey countries,
a finding that has been proposed to indicate how social
impairments and relationship discord may motivate indivi-
duals to seek help.4 Our findings that anxiety and mood
disorders, but not substance use disorders, were more
likely to prompt treatment suggests that a greater effort to
get those with substance use disorders into treatment
is needed. Only 22.1% of those with a substance use
disorder and only 17.3% of those with alcohol abuse
had received any treatment in the 12 months preceding
the interview. This may be due to a low perceived need for
treatment among substance users, especially those with
alcohol use disorders. One national study of U.S. adults
found only 10% of individuals with an alcohol use disorder
felt the need for treatment, and that perceived need for
treatment was predicted most by diagnostic variables
rather than sociodemographic variables, with alcohol-
related legal problems being the greatest predictor.17 Of
course, stigma towards substance use disorders may
also play a role in this large treatment gap.18
Among those who received treatment, younger indivi-
duals (18-34 years) and those with low education and
a low average income were provided less adequate
treatment. However, the type of disorder was not related
to adequacy of treatment. Interestingly, and at odds with
Table 4 Sociodemographic and disorder-type predictors of any and minimally adequate treatment (Argentinean Study of
Mental Health Epidemiology [ASMHE], 2015)
Model effect
Any treatment given any
12-month disorder
Minimally adequate treatment given any
treatment and 12-month disorder
Age (years)
18-34 0.2 (0.1, 0.6) 0.1 (0.0, 0.9)
35-49 0.5 (0.2, 1.3) 0.3 (0.1, 2.2)
50-64 0.8 (0.3, 2.2) 0.3 (0.0, 1.7)
65+ 1.0 (1.0, 1.0) 1.0 (1.0, 1.0)
Overall test of effect Wald-chi 3 df = 25.5, p = 0.000 Wald-chi 3 df = 7.7, p = 0.052
Any anxiety disorder
Yes 3.2 (1.6, 6.2) 0.6 (0.2, 1.7)
No 1.0 (1.0, 1.0) 1.0 (1.0, 1.0)
Overall test of effect Wald-chi 1 df = 12.1, p = 0.001 Wald-chi 1 df = 1.1, p = 0.301
Any mood disorder
Yes 3.6 (2.0, 6.4) 0.9 (0.4, 2.1)
No 1.0 (1.0, 1.0) 1.0 (1.0, 1.0)
Overall test of effect Wald-chi 1 df = 19.0, p = 0.000 Wald-chi 1 df = 0.1, p = 0.765
Any substance disorder
Yes 1.9 (0.7, 5.0) 1.4 (0.4, 5.5)
No 1.0 (1.0, 1.0) 1.0 (1.0, 1.0)
Overall test of effect Wald-chi df = 1.9, p = 0.164 Wald-chi 1 df = 0.3, p = 0.590
Educational attainment
Low 0.4 (0.2, 0.8) 0.1 (0.0, 0.5)
Low-average 0.4 (0.2, 0.7) 0.3 (0.1, 1.5)
High-average 0.7 (0.4, 1.1) 0.2 (0.1, 0.9)
High 1.0 (1.0, 1.0) 1.0 (1.0, 1.0)
Overall test of effect Wald-chi 3 df = 20.9, p = 0.000 Wald-chi 3 df = 15.4, p = 0.002
Income 0.4 (0.2, 0.9) 1.1 (0.3, 4.4)
Low 0.4 (0.2, 1.1) 2.8 (1.0, 8.2)
Low-average 0.7 (0.3, 1.6) 1.8 (0.6, 5.4)
High-average 1.0 (1.0, 1.0) 1.0 (1.0, 1.0)
High Wald-chi 3 df = 6.7, p = 0.081 Wald-chi 3 df = 8.3, p = 0.040
Overall test of effect
Marital status
Never married 1.7 (1.0, 2.8) 1.4 (0.4, 4.9)
Separated/widowed/divorced 0.8 (0.4, 1.6) 1.3 (0.2, 6.3)
Married/cohabitating 1.0 (1.0, 1.0) 1.0 (1.0, 1.0)
Overall test of effect Wald-chi 2 df = 6.8, p = 0.033 Wald-chi 2 df = 0.3, p = 0.842
Sex
Male 0.9 (0.5, 1.5) 1.2 (0.5, 2.9)
Female 1.0 (1.0, 1.0) 1.0 (1.0, 1.0)
Overall test of effect Wald-chi 1 df = 0.1, p = 0.728 Wald-chi 1 df = 0.2, p = 0.680
df = degrees of freedom.
Minimally adequate treatment was defined as receiving four or more visits to any service sector or receiving two or more visits to any service
sector plus at least 1 month of medication or ongoing treatment at interview.
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10 of the 17 WMH Survey countries, there were no
gender differences in treatment use or adequacy.4
The study had limitations that should be considered
in interpreting its results. The first concerns the fact that
institutionalized people (whether in general hospitals,
psychiatric centers, correctional facilities, etc.), individuals
under the age of 18, and individuals living outside the
largest metropolitan areas were excluded from the sampl-
ing frame. Many of these people are likely to have
experienced mental health problems as well, but we have
no information on their service utilization. A second
limitation is that we did not take into account the cost or
insurance coverage of healthcare providers (i.e., if they
were from a prepaid medical care program, from the
patient’s health insurance network, affiliated with a hospi-
tal or outpatient center, etc.) or the number of healthcare
centers available in the studied areas, all of which could
influence access to care. Additionally, because quality
of treatment is difficult to measure, especially across such
a wide array of disorders and treatment types, our defi-
nitions of treatment adequacy reflect quantity and continuity
of treatment rather than quality. The purpose of evaluating
minimally adequate treatment is to determine whether the
treatment individuals receive has any likelihood of being
effective. While determining whether the treatment is
evidence-based would be helpful, many individuals are
unable to name the type of treatment they receive in a way
that would permit establishing whether it is evidence-based.
However, we can more objectively estimate whether treat-
ment was continuous enough to potentially produce a
change, although we recognize this may also be reflective
of treatment adherence or treatment coverage.
Despite these limitations, this study provides – for the
first time – empirical data on service utilization and treat-
ment adequacy for mental health and substance use
disorders in the greater urban areas of Argentina. Data of
this sort are essential for public health policy and plan-
ning. Our findings suggest widespread undertreatment of
psychiatric disorders, particularly substance use disorders,
with an especially high treatment gap among the young,
uneducated, and poor. Additionally, we provide evidence
that one-fourth to over one-half (depending on whether one
uses a broad or more stringent definition of treatment
adequacy) of patients receive treatment that is unlikely to
be effective. Most services are provided by mental health
specialists, which suggests that greater training of general
medical practitioners and integration of mental health
services within primary care settings is recommended.
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